Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

• Päätekijät: Abdolhalim Rajabi (Tekijä), Heidar Sharafi (Tekijä), Seyed Moayed Alavian (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2021-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (Ab) in Iranian PWID before and af...